Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis

Cancer remains the leading cause of death worldwide. In spite of significant advances in targeted and immunotherapeutic approaches, clinical outcomes for cancer remain poor. The aim of the present study was to investigate the potential mechanisms and therapeutic targets of Frondoside A for the treat...

Full description

Bibliographic Details
Main Authors: Guangchun Liu, Shenglin Zhang, Ruoyan Lin, Xudong Cao, Lihong Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1307838/full
_version_ 1797400614615908352
author Guangchun Liu
Shenglin Zhang
Ruoyan Lin
Xudong Cao
Lihong Yuan
author_facet Guangchun Liu
Shenglin Zhang
Ruoyan Lin
Xudong Cao
Lihong Yuan
author_sort Guangchun Liu
collection DOAJ
description Cancer remains the leading cause of death worldwide. In spite of significant advances in targeted and immunotherapeutic approaches, clinical outcomes for cancer remain poor. The aim of the present study was to investigate the potential mechanisms and therapeutic targets of Frondoside A for the treatment of liver, pancreatic, and bladder cancers. The data presented in our study demonstrated that Frondoside A reduced the viability and migration of HepG2, Panc02, and UM-UC-3 cancer cell in vitro. Moreover, we utilized the GEO database to screen and identify for differentially expressed genes (DEGs) in liver, pancreatic, and bladder cancers, which resulted in the identification of 714, 357, and 101 DEGs, respectively. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation were performed using the Metascape database for DEGs that were significantly associated with cancer development. The protein-protein interaction (PPI) networks of the identified DEGs in liver, pancreatic, and bladder cancers were analyzed using Cytoscape 3.9.0 software, and subsequently identified potential key genes that were associated with these networks. Subsequently, their prognostic values were assessed by gene expression level analysis and Kaplan-Meier survival analysis (GEPIA). Furthermore, we utilized TIMER 2.0 to investigate the correlation between the expression of the identified key gene and cancer immune infiltration. Finally, molecular docking simulations were performed to assess the affinity of Frondoside A and key genes. Our results showed a significant correlation between these DEGs and cancer progression. Combined, these analyses revealed that Frondoside A involves in the regulation of multiple pathways, such as drug metabolism, cell cycle in liver cancer by inhibiting the expression of CDK1, TOP2A, CDC20, and KIF20A, and regulates protein digestion and absorption, receptor interaction in pancreatic cancer by down-regulation of ASPM, TOP2A, DLGAP5, TPX2, KIF23, MELK, LAMA3, and ANLN. While in bladder cancer, Frondoside A regulates muscle contraction, complement and coagulation cascade by increase FLNC expression. In conclusion, the present study offers valuable insights into the molecular mechanism underlying the anticancer effects of Frondoside A, and suggests that Frondoside A can be used as a functional food supplement or further developed as a natural anti-cancer drug.
first_indexed 2024-03-09T01:58:06Z
format Article
id doaj.art-cdef98e9ff934b7585bedbe1b2a7f5de
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-09T01:58:06Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-cdef98e9ff934b7585bedbe1b2a7f5de2023-12-08T12:29:17ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-12-011310.3389/fonc.2023.13078381307838Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysisGuangchun Liu0Shenglin Zhang1Ruoyan Lin2Xudong Cao3Lihong Yuan4School of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, ChinaSchool of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, ChinaSchool of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, ChinaDeparment of Chemical and Biological Engineering, University of Ottawa, Ottawa, ON, CanadaSchool of Biosciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, ChinaCancer remains the leading cause of death worldwide. In spite of significant advances in targeted and immunotherapeutic approaches, clinical outcomes for cancer remain poor. The aim of the present study was to investigate the potential mechanisms and therapeutic targets of Frondoside A for the treatment of liver, pancreatic, and bladder cancers. The data presented in our study demonstrated that Frondoside A reduced the viability and migration of HepG2, Panc02, and UM-UC-3 cancer cell in vitro. Moreover, we utilized the GEO database to screen and identify for differentially expressed genes (DEGs) in liver, pancreatic, and bladder cancers, which resulted in the identification of 714, 357, and 101 DEGs, respectively. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation were performed using the Metascape database for DEGs that were significantly associated with cancer development. The protein-protein interaction (PPI) networks of the identified DEGs in liver, pancreatic, and bladder cancers were analyzed using Cytoscape 3.9.0 software, and subsequently identified potential key genes that were associated with these networks. Subsequently, their prognostic values were assessed by gene expression level analysis and Kaplan-Meier survival analysis (GEPIA). Furthermore, we utilized TIMER 2.0 to investigate the correlation between the expression of the identified key gene and cancer immune infiltration. Finally, molecular docking simulations were performed to assess the affinity of Frondoside A and key genes. Our results showed a significant correlation between these DEGs and cancer progression. Combined, these analyses revealed that Frondoside A involves in the regulation of multiple pathways, such as drug metabolism, cell cycle in liver cancer by inhibiting the expression of CDK1, TOP2A, CDC20, and KIF20A, and regulates protein digestion and absorption, receptor interaction in pancreatic cancer by down-regulation of ASPM, TOP2A, DLGAP5, TPX2, KIF23, MELK, LAMA3, and ANLN. While in bladder cancer, Frondoside A regulates muscle contraction, complement and coagulation cascade by increase FLNC expression. In conclusion, the present study offers valuable insights into the molecular mechanism underlying the anticancer effects of Frondoside A, and suggests that Frondoside A can be used as a functional food supplement or further developed as a natural anti-cancer drug.https://www.frontiersin.org/articles/10.3389/fonc.2023.1307838/fullFrondoside Aantitumorintegrated bioinformatical analysismolecular dockingtherapeutic target genes
spellingShingle Guangchun Liu
Shenglin Zhang
Ruoyan Lin
Xudong Cao
Lihong Yuan
Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
Frontiers in Oncology
Frondoside A
antitumor
integrated bioinformatical analysis
molecular docking
therapeutic target genes
title Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
title_full Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
title_fullStr Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
title_full_unstemmed Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
title_short Anti-tumor target screening of sea cucumber saponin Frondoside A: a bioinformatics and molecular docking analysis
title_sort anti tumor target screening of sea cucumber saponin frondoside a a bioinformatics and molecular docking analysis
topic Frondoside A
antitumor
integrated bioinformatical analysis
molecular docking
therapeutic target genes
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1307838/full
work_keys_str_mv AT guangchunliu antitumortargetscreeningofseacucumbersaponinfrondosideaabioinformaticsandmoleculardockinganalysis
AT shenglinzhang antitumortargetscreeningofseacucumbersaponinfrondosideaabioinformaticsandmoleculardockinganalysis
AT ruoyanlin antitumortargetscreeningofseacucumbersaponinfrondosideaabioinformaticsandmoleculardockinganalysis
AT xudongcao antitumortargetscreeningofseacucumbersaponinfrondosideaabioinformaticsandmoleculardockinganalysis
AT lihongyuan antitumortargetscreeningofseacucumbersaponinfrondosideaabioinformaticsandmoleculardockinganalysis